Amlodipine Besylate/Enalapril Maleate

苯磺酸氨氯地平/马来酸依那普利

Report date: 2022/03/08 16:45:18

Base Information

Drug NameAmlodipine Besylate/Enalapril Maleate

Drug Alias NameAmlodipine/Enalapril马来酸依那普利/苯磺酸氨氯地平Amlodipine/enalapril maleateAmlodipine Besylate and Enalapril MaleateGSK-2944404

ClassificationSmall molecules

Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitors

TargetsVoltage-gated calcium channelAngiotensin-converting enzyme

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHypertension

ATC CodeN/A